Two E3 ligases were identified, E3 ubiquitin-protein ligase (MIB2) and E3 ubiquitin protein ligase NEDD4 like (NEDD4L), that were significantly downregulated in the separated sEVs of patients with a first diagnosis of bladder cancer (Table 2). Here, MIB2 is linked to urinary bladder cancer.